Clipping of news on Brazilian Culture, Law and Citizenship
04/12/2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
Anvisa determined the suspension of the distribution, marketing and use of lots 15D041, 15D042, 15D043, 15D044 and 15D045, made in April 2015, in addition to lots with a manufacturing date between May 2015 and December 2015 VARICELL drug (PARAPAHLEBON + POOL) dragée. The products are registered by Vidfarma Industry Medicines Ltda.
The manufacturer informed the Anvisa the voluntary recall of batches after research carried out by the company. The analysis found the existence of blisters with infiltrations, and moistened tablets, crumbling or cracking in those lots.
The company will promote the collection of the existing stock on the market.
If the consumer has one of these lots should contact the health surveillance of your state or municipality or with the Customer Service (SAC) of the company.
The measure is in Resolution RE 924/2016 published on Monday (11/4) in the Official Gazette (DOU).
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.